Share Email Print

Proceedings Paper

Digital holographic microscopy as a screening technology for diabetes
Author(s): Ana Doblas; Jorge Garcia-Sucerquia; Genaro Saavedra; Manuel Martinez-Corral
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

Label-free quantitative phase imaging (QPI) is the hallmark of digital holographic microscopy (DHM). One of the most interesting medical applications of QPI-DHM is that it can be used to analyze illnesses in which the refractive index or/and the morphology of cells/tissues are distorted, from the acquisition of a single image. In this contribution, we obtain the phase maps of red blood cells (RBCs) samples of patients suffering from diabetes mellitus type 1 (DM1) by using a DHM. Our experimental results show that the measured phase values are significantly different between control non-diabetic and diabetic patients. The high correlation coefficient between the phase and the glycated hemoglobin (HbA1C) values determined by the gold standard method to screen diabetes and the clear separation between the two groups indicate that DHM may potentially be used to evaluate long-term glycemic control in diabetic patients as well as to diagnose diabetes.

Paper Details

Date Published: 14 May 2019
PDF: 7 pages
Proc. SPIE 10997, Three-Dimensional Imaging, Visualization, and Display 2019, 109970K (14 May 2019); doi: 10.1117/12.2523416
Show Author Affiliations
Ana Doblas, The Univ. of Memphis (United States)
Jorge Garcia-Sucerquia, Univ. Nacional de Colombia Sede Medellín (Colombia)
Genaro Saavedra, Univ. of Valencia (Spain)
Manuel Martinez-Corral, Univ. of Valencia (Spain)

Published in SPIE Proceedings Vol. 10997:
Three-Dimensional Imaging, Visualization, and Display 2019
Bahram Javidi; Jung-Young Son; Osamu Matoba, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?